MDLZ
38
2
SIG
54
2
AN
49
3
CNX
56
4
CRM
59
2
TAP
61
8
DE
49
9
DTE
67
2
T
51
6
DRI
48
3
CVX
32
3
TJX
50
2
DIS
56
7
STZ
52
3
SE
61
4
FIS
55
2
MTB
60
4
MOS
36
3
NEM
44
3
CCI
30
2
MDLZ
38
2
SIG
54
2
AN
49
3
CNX
56
4
CRM
59
2
TAP
61
8
DE
49
9
DTE
67
2
T
51
6
DRI
48
3
CVX
32
3
TJX
50
2
DIS
56
7
STZ
52
3
SE
61
4
FIS
55
2
MTB
60
4
MOS
36
3
NEM
44
3
CCI
30
2
Financhill
Back

ProShares UltraShort MSCI EAFE Vs. Kymera Therapeutics Industry Stock Comparison

Sell
42

EFU
ProShares UltraShort MSCI EAFE

Last Price:
6.93
Seasonality Move:
-11.57%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
42
ProShares UltraShort MSCI EAFE (EFU) is a Sell

Is ProShares UltraShort MSCI EAFE a Buy, Sell or Hold?

  • The current ProShares UltraShort MSCI EAFE [EFU] share price is $7.13. The Score for EFU is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • EFU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EFU Stock Price Chart

What is ProShares UltraShort MSCI EAFE's stock price today?

  • The ProShares UltraShort MSCI EAFE share price today is $7.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EFU is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

EFU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 55.23 Buy
Chaikin Money Flow: 267 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.82 - 7.1) Buy
Bollinger Bands (100): (6.97 - 7.63) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

EFU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.02 Buy
20-day SMA: 6.92 Buy
50-day SMA: 7.13 Buy
200-day SMA: 7.68 Sell
8-day EMA: 7.02 Buy
20-day EMA: 7 Buy
50-day EMA: 7.11 Buy
200-day EMA: 7.8 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares UltraShort MSCI EAFE Earnings Growth & EFU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares UltraShort MSCI EAFE Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):